User profiles for Karin Purshouse
 | Karin PurshouseUniversity of Edinburgh Verified email at ed.ac.uk Cited by 2985 |
[HTML][HTML] COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
…, R Pettengell, T Powles, EA Protheroe, K Purshouse… - The Lancet, 2020 - thelancet.com
Background Individuals with cancer, particularly those who are receiving systemic anticancer
treatments, have been postulated to be at increased risk of mortality from COVID-19. This …
treatments, have been postulated to be at increased risk of mortality from COVID-19. This …
[HTML][HTML] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
…, T Powles, EA Protheroe, K Purshouse… - The Lancet …, 2020 - thelancet.com
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
…, ND Robinson, SE Scanlon, KR Purshouse… - Science translational …, 2017 - science.org
2-Hydroxyglutarate (2HG) exists as two enantiomers, (R)-2HG and (S)-2HG, and both are
implicated in tumor progression via their inhibitory effects on α-ketoglutarate (αKG)–dependent …
implicated in tumor progression via their inhibitory effects on α-ketoglutarate (αKG)–dependent …
[HTML][HTML] The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
The availability of bromodomain and extra-terminal inhibitors (BETi) has enabled
translational epigenetic studies in cancer. BET proteins regulate transcription by selectively …
translational epigenetic studies in cancer. BET proteins regulate transcription by selectively …
Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19
Importance Large cohorts of patients with active cancers and COVID-19 infection are needed
to provide evidence of the association of recent cancer treatment and cancer type with …
to provide evidence of the association of recent cancer treatment and cancer type with …
[HTML][HTML] COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
AJX Lee, K Purshouse - British Journal of Cancer, 2021 - nature.com
The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt
their practice in the aim of protecting patients. Early evidence from China indicated that …
their practice in the aim of protecting patients. Early evidence from China indicated that …
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
In December, 2019, several cases of acute respiratory syndrome in Hubei province, China
were identified; these were the first described cases of COVID-19. The causative virus, SARS-…
were identified; these were the first described cases of COVID-19. The causative virus, SARS-…
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent …
…, NA Campton, G Cook, K Purshouse… - British Journal of …, 2022 - Wiley Online Library
Patients with haematological malignancies have a high risk of severe infection and death
from SARS‐CoV‐2. In this prospective observational study, we investigated the impact of …
from SARS‐CoV‐2. In this prospective observational study, we investigated the impact of …
Challenges to DNA replication in hypoxic conditions
N Ng, K Purshouse, IP Foskolou, MM Olcina… - The FEBS …, 2018 - Wiley Online Library
The term hypoxia refers to any condition where insufficient oxygen is available and therefore
encompasses a range of actual oxygen concentrations. The regions of tumours adjacent to …
encompasses a range of actual oxygen concentrations. The regions of tumours adjacent to …
Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells
K Purshouse, ET Friman, S Boyle, PS Dewari, V Grant… - Elife, 2022 - elifesciences.org
Extrachromosomal DNA (ecDNA) are frequently observed in human cancers and are
responsible for high levels of oncogene expression. In glioblastoma (GBM), ecDNA copy number …
responsible for high levels of oncogene expression. In glioblastoma (GBM), ecDNA copy number …
